Lung & Respiratory Disease Clinical Trials Update: Week 19, 2026

Published May 8, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)

This large Phase 3 trial tested a new way to use asthma inhalers by combining maintenance and relief medicines into one approach for adults whose asthma is not fully controlled. More than 1700 patients from different countries took part, and the results are now available. This treatment method may help people manage their asthma symptoms more easily and reduce serious asthma attacks, offering a more flexible option for daily care.

My Path to Quit Tobacco

This Phase 4 study is focused on helping Black adults quit smoking by testing three different approaches, including culturally tailored programs. The goal is to see if these more personalized treatments work better than standard quitline services. With a plan to enroll 1550 participants across the United States, this trial could lead to more effective support for quitting smoking in this community.

Integrating Financial Coaching and Smoking Cessation Coaching

This Phase 3 trial is exploring a combined support program that offers both financial coaching and smoking cessation counseling for adults who smoke and have low income. The idea is to address money-related stress alongside smoking habits to improve quitting success. Recruiting 900 participants in the United States, this study may provide a new way to help people quit smoking by tackling multiple challenges at once.

Diaphragm Response in Elderly for Acute Monitoring

This study is testing a non-invasive ultrasound technique to quickly assess breathing muscle function in elderly patients with sudden breathing difficulties. By evaluating the diaphragm’s response, doctors may better predict which patients are at risk of severe respiratory problems. This could improve emergency care for older adults in France, especially those aged 75 and above.

The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure

This trial combines advice, nicotine replacement, and mobile support to help adult smokers who live with children quit smoking. The goal is to protect children from harmful tobacco smoke exposure by encouraging parents to stop smoking. Recruiting 1200 participants in China, this study may offer a more effective way to support families in creating healthier homes.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.